Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Medicines for Malaria Venture
Medicines for Malaria Venture
Activities:
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Novartis and MMV move to Phase III study to treat uncomplicated malaria
As the world faces emerging resistance to current malaria treatments, new medicines are needed to continue the fight toward elimination
Research & Development
Novartis expands partnership with Medicines for Malaria Venture
To develop next-generation antimalarial treatment in collaboration with the Bill & Melinda Gates Foundation
Research & Development
World Malaria Day looks forward to single tablet treatment
Scientists investigating a new substance that could potentially be used as a single dose therapy in the future
Research & Development
Merck Serono links up with MMV to develop antimalarial
Allows Merck Serono to continue to focus on developing therapies for neglected tropical diseases
Research & Development
Evotec agrees compound management collaboration with Medicines For Malaria Venture
Evotec will use its compound management services to support MMV\'s efforts to distribute research tools to the global malaria research community
Research & Development
Sanofi-aventis and MMV to develop malaria treatments
Sign joint three-year research project agreement
Research & Development
MMV and Anacor to identify new malaria medicines
Anacor’s boron chemistry will be used to develop new therapeutics
Subscribe now